Gilleran, Jason
Diokno, Ananias C.
Ward, Elijah
Sirls, Larry
Hasenau, Deborah
Giordano, Jennifer
Shea, Evelyn
Bartolone, Sarah N.
Lamb, Laura E.
Chancellor, Michael B. https://orcid.org/0000-0001-9480-8972
Funding for this research was provided by:
Aikens (Center for Neurourology Research)
Article History
Received: 16 June 2020
Accepted: 25 March 2021
First Online: 11 April 2021
Declarations
:
: Dr. Michael Chancellor, a urologist and researcher at William Beaumont Hospital, is one of the inventors of this cell process. Dr. Chancellor receives royalty payments for the cell process and consulting from Cook MyoSite, the company which owns the rights to the cell process and prepares the cells for re-implantation.
: Informed consent was obtained from each subject before performing any screening procedures by the Principal Investigator, co-Investigator, or research coordinator.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.